20 years real-world data on disease burden, patient experience & unmet needs in Refractory #RheumatoidArthritis ▶️Higher glucocorticoid & opioid use ▶️Greater comorbidity & symptom burden ▶️More rheumatology visits #ACR23 👉🏽https://t.co/CAUorjQbvN by @KristinWipfler @Dr_K et al https://t.co/vx1aOZizfE